Advisory Research Inc. lowered its stake in Chain Bridge I (NASDAQ:CBRG – Get Rating) by 20.2% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 169,210 shares of the company’s stock after selling 42,810 shares during the period. Advisory Research Inc. owned approximately 0.59% of Chain Bridge I worth $1,707,000 as of its most recent filing with the SEC.
A number of other hedge funds also recently modified their holdings of CBRG. Saba Capital Management L.P. grew its position in Chain Bridge I by 7.2% in the third quarter. Saba Capital Management L.P. now owns 995,387 shares of the company’s stock valued at $10,043,000 after acquiring an additional 66,887 shares during the last quarter. First Trust Capital Management L.P. bought a new position in Chain Bridge I in the third quarter valued at about $316,000. Shaolin Capital Management LLC grew its position in Chain Bridge I by 12.4% in the third quarter. Shaolin Capital Management LLC now owns 362,373 shares of the company’s stock valued at $3,656,000 after acquiring an additional 39,873 shares during the last quarter. Aristeia Capital LLC grew its position in Chain Bridge I by 16.8% in the third quarter. Aristeia Capital LLC now owns 350,400 shares of the company’s stock valued at $3,536,000 after acquiring an additional 50,400 shares during the last quarter. Finally, Wolverine Asset Management LLC bought a new position in Chain Bridge I in the third quarter valued at about $68,000. Institutional investors own 64.84% of the company’s stock.
Chain Bridge I Price Performance
Shares of CBRG stock opened at $10.42 on Wednesday. The business’s 50-day moving average price is $10.35 and its 200-day moving average price is $10.21. Chain Bridge I has a 12 month low of $9.90 and a 12 month high of $10.42.
Chain Bridge I Company Profile
Chain Bridge I does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It also intends to focus on partnering with a technology company that will advance the United States national security and intelligence interests.
Further Reading
- Get a free copy of the StockNews.com research report on Chain Bridge I (CBRG)
- Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
- GitLab Crashes On Guidance; Analysts DefendĀ
- Healthcare Stocks With at Least 30 Years of Dividend Increases
- Coinbase Pops As SVB Crumbles To Dust
- Airlines Update Guidance, Shares Head For Different Destinations
Receive News & Ratings for Chain Bridge I Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chain Bridge I and related companies with MarketBeat.com's FREE daily email newsletter.